Physician profile
Rami Basatneh
NPI 1639734296
$22,487.68
in general payments reported to CMS, 2019-2025
26 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.91 · 2022: $5,117 · 2023: $4,972 · 2024: $11K · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,259 · Consulting Fee: $5,320 · Food and Beverage: $3,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,258.92 |
| Consulting Fee | $5,320.00 |
| Food and Beverage | $3,775.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $10,560.53 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $2,494.41 | 2022-2025 | Truelok, Physio-Stim |
| Paragon 28, INC. | $1,836.88 | 2022-2023 | Portfolio |
| Stryker Corporation | $1,813.59 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Augment Injectable |
| Vilex LLC | $1,525.67 | 2023 | |
| Medical Device Business Services, INC. | $1,380.14 | 2023 | Na |
| Treace Medical Concepts, INC. | $1,306.69 | 2023 | |
| Medline Industries LP | $358.39 | 2025 | |
| Smith+Nephew, INC. | $250.70 | 2023-2025 | Smart Tsf, Stravix, Footprint |
| Arthrex, INC. | $200.40 | 2023 | |
| Depuy Synthes Sales INC. | $168.92 | 2022-2025 | Motoband, Healix Knotless Peek, Gryphon Orthocord |
| Pylant Medical | $127.40 | 2023 | |
| Medtronic, INC. | $107.10 | 2024-2025 | Intellis Adaptivestim, Venaseal |
| Vaporox, INC. | $43.91 | 2023 | Vht-200 Wound Treatment System |
| Convatec INC. | $40.08 | 2023-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $37.13 | 2023-2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $35.84 | 2023-2025 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $34.91 | 2024-2025 | |
| Mimedx Group, INC. | $33.91 | 2024-2025 | |
| Kerecis Limited | $27.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $20.87 | 2024 | |
| Ossio INC | $18.58 | 2023 | |
| Cashflow Solutions, LLC | $17.30 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Osteomed LLC | $16.91 | 2021 | |
| Advanced Oxygen Therapy INC. | $16.14 | 2024 | Topical Oxygen Chamber For Extremities |
| Davol INC. | $13.66 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Basatneh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.